Literature DB >> 10333357

GnRH mRNA and protein expression in human preimplantation embryos.

E M Casañ1, F Raga, M L Polan.   

Abstract

Gonadotrophin-releasing hormone (GnRH) regulates gonadotrophin biosynthesis and release in the anterior pituitary via specific receptors. Extrapituitary expression and action of GnRH have been demonstrated in several species. A possible role for GnRH in preimplantation embryonic development, endometrial preparation, and the implantation process has been previously suggested. Moreover, the presence of an immunoreactive GnRH in preimplantation embryos has been demonstrated in different species; however, there are no data for human embryos. We postulate that in humans GnRH may play a role in preimplantation embryonic development as well as in the implantation process. To examine this hypothesis, we assessed GnRH and GnRH-receptor mRNA and protein expression in human preimplantation embryos with three pronuclei. GnRH is expressed in peri-implantation human embryos at both the mRNA and protein level. GnRH-receptor mRNA is also present in the embryos studied. Immunohistochemical localization of GnRH showed intense staining in all the blastomeres at morula stage as well as in the trophectoderm and inner cell mass of the blastocysts. The results of the present study challenge the widely held view that GnRH has a predominantly central action, and suggests a pathway to describe a local role for the GnRH system in successful preimplantation embryonic development and implantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333357     DOI: 10.1093/molehr/5.3.234

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  14 in total

1.  Gonadotropin-releasing hormone messenger ribonucleic acid and protein expression in Vero cells.

Authors:  H Y Huang; F Raga; J S Kruessel; Y Wen; Y K Soong; M L Polan
Journal:  J Assist Reprod Genet       Date:  2001-05       Impact factor: 3.412

Review 2.  From nose to brain: development of gonadotrophin-releasing hormone-1 neurones.

Authors:  S Wray
Journal:  J Neuroendocrinol       Date:  2010-07       Impact factor: 3.627

3.  Does lower dose of long-acting triptorelin maintain pituitary suppression and produce good live birth rate in long down-regulation protocol for in-vitro fertilization?

Authors:  Xin Chen; Shu-Xian Feng; Ping-Ping Guo; Yu-Xia He; Yu-Dong Liu; De-Sheng Ye; Shi-Ling Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

4.  Embryonic early-cleavage rate is decreased with aging in GnRH agonist but not inantagonist protocols.

Authors:  Wen-Jui Yang; Yu-Chyi Hwang; Chih-Sheng Lin; Yuh-Ming Hwu; Robert Kuo-Kuang Lee; Shun-Yu Hsiao
Journal:  J Assist Reprod Genet       Date:  2015-03-20       Impact factor: 3.412

5.  Administration effects of single-dose GnRH agonist for luteal support in females undertaking IVF/ICSI cycles: A meta-analysis of randomized controlled trials.

Authors:  Mengling Song; Chunlian Liu; Rong Hu; Feimiao Wang; Zhenghao Huo
Journal:  Exp Ther Med       Date:  2019-11-27       Impact factor: 2.447

6.  Artificial Cycle with or without a Depot Gonadotropin-releasing Hormone Agonist for Frozen-thawed Embryo Transfer: An Assessment of Infertility Type that Is Most Suitable.

Authors:  Di Xie; Fan Chen; Shou-Zhen Xie; Zhi-Lan Chen; Ping Tuo; Rong Zhou; Juan Zhang
Journal:  Curr Med Sci       Date:  2018-08-20

Review 7.  Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.

Authors:  João Batista A Oliveira; Ricardo Baruffi; Cláudia G Petersen; Ana L Mauri; Mario Cavagna; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2010-09-08       Impact factor: 5.211

8.  Granzyme G is expressed in the two-cell stage mouse embryo and is required for the maternal-zygotic transition.

Authors:  Tung-Chou Tsai; William Lin; Shang-Hsun Yang; Winston T K Cheng; En-Hui Cheng; Maw-Sheng Lee; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  BMC Dev Biol       Date:  2010-08-12       Impact factor: 1.978

Review 9.  GnRH, anosmia and hypogonadotropic hypogonadism--where are we?

Authors:  Paolo E Forni; Susan Wray
Journal:  Front Neuroendocrinol       Date:  2014-10-13       Impact factor: 8.606

10.  Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome.

Authors:  Dattaprasad B Inamdar; Abha Majumdar
Journal:  J Hum Reprod Sci       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.